Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx.
Pentheroudakis G, Nicolaou I, Kotoula V, Fountzilas E, Markou K, Eleftheraki AG, Fragkoulidi A, Karasmanis I, Tsigka A, Angouridakis N, Vlachtsis K, Nikolaou A, Pavlidis N, Fountzilas G. Pentheroudakis G, et al. Among authors: fountzilas g, fountzilas e. Oral Oncol. 2012 Aug;48(8):709-16. doi: 10.1016/j.oraloncology.2012.02.002. Epub 2012 Feb 25. Oral Oncol. 2012. PMID: 22366437
Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.
Fountzilas E, Markou K, Vlachtsis K, Nikolaou A, Arapantoni-Dadioti P, Ntoula E, Tassopoulos G, Bobos M, Konstantinopoulos P, Fountzilas G, Spentzos D. Fountzilas E, et al. Among authors: fountzilas g. Ann Oncol. 2012 Aug;23(8):2146-2153. doi: 10.1093/annonc/mdr576. Epub 2012 Jan 4. Ann Oncol. 2012. PMID: 22219018 Free PMC article.
Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
Mountzios G, Kostopoulos I, Kotoula V, Sfakianaki I, Fountzilas E, Markou K, Karasmanis I, Leva S, Angouridakis N, Vlachtsis K, Nikolaou A, Konstantinidis I, Fountzilas G. Mountzios G, et al. Among authors: fountzilas g, fountzilas e. PLoS One. 2013;8(1):e54048. doi: 10.1371/journal.pone.0054048. Epub 2013 Jan 24. PLoS One. 2013. PMID: 23365645 Free PMC article.
Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer.
Psyrri A, Kotoula V, Fountzilas E, Alexopoulou Z, Bobos M, Televantou D, Karayannopoulou G, Krikelis D, Markou K, Karasmanis I, Angouridakis N, Kalogeras KT, Nikolaou A, Fountzilas G. Psyrri A, et al. Among authors: fountzilas g, fountzilas e. Oral Oncol. 2014 Apr;50(4):298-305. doi: 10.1016/j.oraloncology.2014.01.005. Epub 2014 Jan 21. Oral Oncol. 2014. PMID: 24461629
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
Pentheroudakis G, Kotoula V, Fountzilas E, Kouvatseas G, Basdanis G, Xanthakis I, Makatsoris T, Charalambous E, Papamichael D, Samantas E, Papakostas P, Bafaloukos D, Razis E, Christodoulou C, Varthalitis I, Pavlidis N, Fountzilas G. Pentheroudakis G, et al. Among authors: fountzilas g, fountzilas e. BMC Cancer. 2014 Feb 20;14:111. doi: 10.1186/1471-2407-14-111. BMC Cancer. 2014. PMID: 24555920 Free PMC article.
Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.
Fountzilas E, Kotoula V, Tikas I, Manousou K, Papadopoulou K, Poulios C, Karavasilis V, Efstratiou I, Pectasides D, Papaparaskeva K, Varthalitis I, Christodoulou C, Papatsibas G, Chrisafi S, Glantzounis GK, Psyrri A, Aravantinos G, Koliou GA, Koukoulis GK, Pentheroudakis GE, Fountzilas G. Fountzilas E, et al. Among authors: fountzilas g. Oncotarget. 2018 Nov 2;9(86):35623-35638. doi: 10.18632/oncotarget.26256. eCollection 2018 Nov 2. Oncotarget. 2018. PMID: 30479693 Free PMC article.
42 results